Serial Number
99192698
Owner
Cortexa Therapeutics, Inc.Attorney
Michael K. KellyFirst Use Date
Apr 20, 2025
Filing Date
May 19, 2025
CORTEXA THERAPEUTICS Trademark
Serial Number: 99192698
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Michael K. Kelly Newman Jones, PLLC
14747 N Northsight Blvd
Ste 111-143
Scottsdale, AZ 85260
United States
Trademark Details
Filing Date
May 19, 2025
Registration Date
Not Registered
First Use Anywhere
April 20, 2025
First Use in Commerce
April 20, 2025
Goods & Services
Biotechnology research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the field of Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD), Frontotemporal Dementia (FTD), Huntington’s Disease, and vascular dementia; Scientific research for medical purposes in the field of Central Nervous System (CNS) disorders; Scientific study and research in the field(s) of treatment and management of CNS disorders; Laboratory research services relating to pharmaceuticals; Clinical research in the field of Central Nervous System (CNS) disorders medical treatment; Testing of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others in the field of Central Nervous System (CNS) disorders treatments; Research and development services in the field of pharmaceutical preparations; Laboratory services for biomanufacturing CRO-contracted compounds; Laboratory research in the field of chemical analyses for analog development and PK/PD profiling; Pharmaceutical research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development and consultation related thereto in the field of pharmaceutical therapeutic strategy and trial design advisory; Medical and scientific research in the field of Amyotrophic Lateral Sclerosis (ALS)
Providing medical information in the field of Amyotrophic Lateral Sclerosis (ALS); Pharmaceutical advice; Providing health information in the field of Central Nervous System (CNS) disorders; Medical analysis services relating to the treatment of persons; Providing information in the field of the diagnosis and treatment of Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD), Frontotemporal Dementia (FTD), Huntington’s Disease, and vascular dementia via a website; Consulting services in the field of the diagnosis and treatment of Amyotrophic Lateral Sclerosis (ALS); Consulting services to health care providers in the field of treating life-changing or life-threatening diseases; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of Central Nervous System (CNS) disorders; Medical screening services in the field of Central Nervous System (CNS) disorders